These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37927318)

  • 1. Randomized Controlled Study of Cooled vs Room-Temperature Artificial Tears for Reducing Ocular Surface Irritation After Intravitreal Injection.
    Mani S; Jin HD; Shonka B; Fortenbach CR; Russell JF
    J Vitreoretin Dis; 2023; 7(4):310-315. PubMed ID: 37927318
    [No Abstract]   [Full Text] [Related]  

  • 2. Pain control and subconjunctival haemorrhage after intravitreal injection using cooled anaesthetic eyedrops and antiseptics: A prospective, double-blind, randomized controlled trial.
    Moshkovsky R; Golan N; Aviel Gadot E; Bar A; Achiron A; Fischer N; Spierer O
    Acta Ophthalmol; 2024 Jun; 102(4):e587-e594. PubMed ID: 37853924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of ocular rinse volume on surface irritation after povidone-iodine preparation for intravitreal injections: a randomized controlled trial.
    Jamshidi F; Jin HD; Bruce A; Kutteh M; Ding K; Riaz KM; Kingsley RM; Shah VA
    Int J Retina Vitreous; 2023 Sep; 9(1):59. PubMed ID: 37770983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of punctal plugs in reducing ocular surface irritation after povidone-iodine preparation of intravitreal injection-a randomized trial.
    Jin HD; Surbeck JW; Marsh HR; Ding K; Kingsley RM; Riaz KM; Park SSK; Shah VA
    Eye (Lond); 2022 Mar; 36(3):568-574. PubMed ID: 33746207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aqueous Chlorhexidine Compared with Povidone-Iodine as Ocular Antisepsis before Intravitreal Injection: A Randomized Clinical Trial.
    Ali FS; Jenkins TL; Boparai RS; Obeid A; Ryan ME; Wibblesman TD; Chiang A; Garg SJ;
    Ophthalmol Retina; 2021 Aug; 5(8):788-796. PubMed ID: 33221515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Artificial Tears in Patients Undergoing Treatment with Anti-VEGF Intravitreal Injections.
    Pastor-Pascual F; Pastor-Pascual R; Gálvez-Perez P; Dolz-Marco R; Gallego-Pinazo R
    Clin Ophthalmol; 2022; 16():3959-3972. PubMed ID: 36474999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypochlorous acid antiseptic washout improves patient comfort after intravitreal injection: A patient reported outcomes study.
    Fam A; Finger PT; Tomar AS; Garg G; Chin KJ
    Indian J Ophthalmol; 2020 Nov; 68(11):2439-2444. PubMed ID: 33120635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical cyclosporine A therapy for dry eye syndrome.
    de Paiva CS; Pflugfelder SC; Ng SM; Akpek EK
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD010051. PubMed ID: 31517988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical pharmacologic interventions versus placebo for epidemic keratoconjunctivitis.
    Liu SH; Hawkins BS; Ng SM; Ren M; Leslie L; Han G; Kuo IC
    Cochrane Database Syst Rev; 2022 Mar; 3(3):CD013520. PubMed ID: 35238405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Inflammatory and Cytological Effect of Repeated Povidone-Iodine Application in Patients Receiving Intravitreal Injections.
    Akbulut E; Kirik F; Ekinci Aslanoglu C; Hekimoglu ER; Haciosmanoglu Aldogan E; Ozdemir MH
    Eye Contact Lens; 2024 Feb; 50(2):73-78. PubMed ID: 37791838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a 0.9% sodium chloride ophthalmic solution on the ocular surface of symptomatic contact lens wearers.
    Barabino S; Rolando M; Camicione P; Chen W; Calabria G
    Can J Ophthalmol; 2005 Feb; 40(1):45-50. PubMed ID: 15825529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-Intravitreal injection pain reduction using topical NSAIDS: A comparative study.
    Shtayer C; Lily Okrent Smolar A; Elmalak M; Abayev L; Grzybowski A; Moisseiev E
    Eur J Ophthalmol; 2023 Sep; ():11206721231201176. PubMed ID: 37691285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Punctal occlusion for dry eye syndrome.
    Ervin AM; Law A; Pucker AD
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD006775. PubMed ID: 28649802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical ketorolac as an adjunctive treatment with intravitreal bevacizumab in the management of diabetic macular edema: A double-masked placebo-controlled randomized clinical trial.
    Nikkhah H; Niazpour Moez R; Entezari M; Ramezani A; Hassanpour K; Karimi S; Yaseri M
    Graefes Arch Clin Exp Ophthalmol; 2021 Oct; 259(10):2949-2959. PubMed ID: 33856549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pain Control after Intravitreal Injection Using Topical Nepafenac 0.3% or Pressure Patching: A Randomized, Placebo-Controlled Trial.
    Kaplan RI; Drinkwater OJ; Lee RH; Chod RB; Barash A; Giovinazzo JV; Gologorsky D; Jansen ME; Rosen RB; Gentile RC
    Ophthalmol Retina; 2019 Oct; 3(10):860-866. PubMed ID: 31221565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Over the counter (OTC) artificial tear drops for dry eye syndrome.
    Pucker AD; Ng SM; Nichols JJ
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD009729. PubMed ID: 26905373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between Serial Intravitreal Injections and Dry Eye.
    Malmin A; Thomseth VM; Førland PT; Khan AZ; Hetland HB; Chen X; Haugen IK; Utheim TP; Forsaa VA
    Ophthalmology; 2023 May; 130(5):509-515. PubMed ID: 36693594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of serial intravitreal injections on measures of dry eye: A systemic review and meta-analysis.
    Gao M; Xia F; Wang P; Feng Z; Wang X
    Cont Lens Anterior Eye; 2024 Apr; 47(2):102127. PubMed ID: 38350814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of handholding during intravitreal injections.
    Shaughnessy D; Powell S; O'Toole L
    Ir J Med Sci; 2023 Feb; 192(1):441-445. PubMed ID: 35332505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Carboxymethylcellulose Sodium plus Glycerin (Optive®) in Ocular Discomfort after Anti-Vascular Endothelial Growth Factor Intravitreal Injection Therapy: A Prospective Study.
    Karcenty M; Jung C; Souied EH; Delacour C; Miere A; Gueunoun S; Capuano V; Semoun O
    Ophthalmologica; 2021; 244(3):187-192. PubMed ID: 33120388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.